SIGLEC12 and urogenital neoplasm: In this study, we identified epigenetic hypomethylation as a regulatory mechanism for SIGLEC12 overexpression, and methylation deregulation of SIGLEC12 may serve as a universal event in bladder tumorigenesis and progression.